DEUTSCHE BANK AG\ - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 35 filers reported holding ACORDA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$7,962,000
+175.5%
9,361,000
+185.8%
0.01%
+150.0%
Q1 2019$2,890,000
+62.5%
3,275,000
+52.3%
0.00%
+100.0%
Q4 2018$1,778,000
-77.3%
2,150,000
-76.9%
0.00%
-50.0%
Q3 2018$7,849,000
-38.4%
9,300,000
-29.5%
0.00%
-50.0%
Q2 2018$12,748,000
+75.3%
13,192,000
+64.9%
0.00%
+33.3%
Q1 2018$7,271,000
+89.7%
8,000,000
+76.7%
0.00%
+50.0%
Q4 2017$3,833,000
-27.3%
4,527,000
-22.5%
0.00%
-50.0%
Q3 2017$5,269,000
-32.1%
5,840,000
-35.4%
0.00%
-33.3%
Q2 2017$7,761,000
+78.9%
9,045,000
+77.2%
0.01%
+100.0%
Q1 2017$4,339,000
-27.0%
5,105,000
-34.8%
0.00%
-40.0%
Q4 2016$5,947,000
+5.3%
7,825,000
+13.0%
0.01%
+25.0%
Q3 2016$5,648,000
+16.0%
6,925,000
+24.2%
0.00%
+33.3%
Q2 2016$4,871,000
+154.6%
5,576,000
+158.4%
0.00%
+200.0%
Q1 2016$1,913,000
-74.9%
2,158,000
-67.5%
0.00%
-80.0%
Q4 2015$7,627,000
+69.0%
6,633,000
+32.6%
0.01%
+66.7%
Q3 2015$4,512,000
+25.5%
5,001,000
+40.8%
0.00%
+50.0%
Q2 2015$3,594,000
+29.0%
3,551,000
+30.4%
0.00%0.0%
Q1 2015$2,787,000
+227.1%
2,723,000
+267.0%
0.00%
+100.0%
Q4 2014$852,000
+10.1%
742,000
-0.7%
0.00%
Q3 2014$774,000747,0000.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
LINDEN ADVISORS LP 15,510,000$16,119,0003.21%
GRACE BROTHERS MANAGEMENT LLC 2,500,000$2,592,0002.44%
Mohican Financial Management, LLC 3,000,000$3,113,0001.52%
Wellesley Asset Management 20,902$21,872,0001.36%
Fore Research & Management, LP 31,595,000$32,937,0000.97%
Man Investments (CH) AG 1,700,000$1,787,0000.93%
SYMPHONY ASSET MANAGEMENT LLC 7,834,000$8,128,0000.84%
BASSO CAPITAL MANAGEMENT, L.P. 5,000,000$5,150,0000.79%
Baker Brothers Advisors 60,000,000$62,050,0000.78%
CAMDEN ASSET MANAGEMENT L P /CA 10,225,000$10,608,0000.44%
View complete list of ACORDA THERAPEUTICS INC shareholders